f Downregulation of major histocompatibility complex class I (MHC-I) by HIV-1 Nef protein is indispensable for evasion of protective immunity by HIV-1. Though it has been suggested that the N-terminal region of Nef contributes to the function by associating with a mu-1A subunit of adaptor protein 1, the structural basis of the interaction between Nef and mu-1A remains elusive. We found that a tripartite hydrophobic motif (Trp13/Val16/Met20) in the N terminus of Nef was required for the MHC-I downregulation. Importantly, the motif functioned as a noncanonical mu-1A-binding motif for the interaction with the tyrosine motif-binding site of the mu-1A subunit. Our findings will help understanding of how HIV-1 evades the antiviral immune response by selectively redirecting the cellular protein trafficking system.
V16R, 5=-GTGATTGGATGGCCAGCTCGGAGGGAAAGAATGAG-3= and 5=-CTCATTCTTTCCCTCCGAGCTGGCCATCCAATCAC-3=; for E18A, 5=-GATTGGATGGCCAGCTGTAAGGGCCAGAATGAG-3= and 5=-CTCATTCTGGCCCTTACAGCTGGCCATCCAATC-3=; for E18D, 5=-GATTGGATGGCCAGCTGTAAGGGACAGAATGAG-3= and 5=-CT CATTCTGTCCCTTACAGCTGGCCATCCAATC-3=; and for E18R, 5=-GATTGGATGGCCAGCTGTAAGGCGGAGAATGAG-3= and 5=-CTCA TTCTCCGCCTTACAGCTGGCCCATCCAATC-3=.
All constructs described above were verified by nucleotide sequencing with a BigDye Terminator cycle sequencing kit (version 1.1) and a Genetic Analyzer (ABI PRISM 3100; Applied Biosystems, Foster City, CA). The A-MLV-Env expression plasmid SA-A-MLV vector (34) and the VSV-G expression construct pCMV-G (51) were used for the production of pseudotyped viruses by cotransfection with pNL4-3 or its variants as previously described (3) .
Cell culture. 293T cells were cultured in Dulbecco's modified Eagle's medium with 5% fetal bovine serum (Sigma-Aldrich, St. Louis, MO) and antibiotics. CEM-GFP cells contain HIV-1 long-terminal-repeat-driven green fluorescence protein (GFP) cDNA, and GFP expression is inducible by Tat (14) . The cells and Jurkat cells were maintained with RPMI 1640 with 10% fetal bovine serum and antibiotics.
Antibodies. In this study, we used the following antibodies: a rabbit polyclonal anti-Nef antibody (2949) and an AIDS-patient serum (provided by the AIDS Research and Reference Reagent Program, NIH), an RPE-cy5-conjugated or a nonlabeled anti-CD4 monoclonal antibody (MAb) (MT310; Dako, Japan), anti-HLA-ABC MAbs (B9.12.1, Beckman Coulter, Fullerton, CA; W6/32, ebioscience, San Diego, CA), an allophycocyanin (APC)-conjugated goat anti-mouse Ig (BD Bioscience, San Jose, CA), an anti-gamma-adaptin MAb (100/3; Sigma), an anti-NeuN MAb (A60; Millipore, Hercules, CA), and a rabbit anti-mu-1A antibody (Sigma) (28) .
Transfection and preparation of viruses, cell lysates, and viral lysates and Western blotting. 293T cells were transfected with pNL4-3 or its nef mutants by the use of Lipofectamine 2000 (Invitrogen, San Diego, CA). Transfected 293T cells (2 ϫ 10 7 ) and culture supernatants were harvested at 48 h posttransfection. The culture supernatants were filtered (0.45-m-pore-size filter), quantified for p24 capsid antigen levels by enzyme-linked immunosorbent assay (ELISA) (ZeptoMetrix, Buffalo, NY), and stored at Ϫ80°C. The cells were washed with phosphatebuffered saline (PBS) twice and resuspended in PBS with protease inhibitor cocktails (Complete Mini; Roche, Mannheim, Germany) and lysed with 2ϫ sample buffer for 5 min at 95°C. For harvesting viral particles, the virus supernatants were ultracentrifuged through a cushion of 20% (wt/ vol) sucrose-PBS at 110,000 ϫ g for 60 min at 4°C and then lysed with 2ϫ sample buffer for 5 min at 95°C. The protocol of Western blotting was based on a previously described method (3) . To detect the Nef and p24 proteins in cell lysates and viral particles, we used anti-Nef polyclonal antibody and AIDS-patient serum, respectively. Immunoreactive proteins were visualized using chemiluminescence (Immobilon; Millipore). Downregulation assay. CEM-GFP cells (5 ϫ 10 5 ) were infected with viruses by spinoculation at 30°C and 1,200 ϫ g for 2 h as previously described (30) . The cells were immediately transferred to the T25 flask with fresh medium and cultured at 37°C. At 48 h after infection, the cells were incubated with an RPE-cy5-conjugated anti-CD4 MAb or an anti-HLA-ABC MAb, followed by treatment with an APC-conjugated anti-mouse Ig at 4°C for 30 min. The fluorescence intensity for GFP and MHC-I was detected by a FACSCalibur flow cytometer (BD Bioscience).
Immunofluorescence staining. At 24 h after infection, HIV-1-infected cells were transferred to chamber slides. Cells were incubated at 37°C for 30 min and centrifuged at 600 rpm for 5 min at room temperature. Cells were fixed with 3% paraformaldehyde at room temperature for 15 min, washed once with PBS, and incubated with a primary antibody solution overnight at 4°C. We subjected the following primary antibodies to double staining: an anti-CD4 MAb (MT310) (1:1,000), an anti-HLA-ABC MAb (W6/32) (1:5,000), and an anti-Nef polyclonal antibody (1: 5,000). After one wash with PBS, cells were incubated with an Alexa 555-conjugated anti-rabbit IgG antibody or an Alexa 488-conjugated antimouse IgG antibody for 1 h at 4°C. After two washes with PBS and one wash with distilled water, we mounted samples on soft-mount solution (Wako). We subjected the following antibodies to triple staining: an antiNef MAb (1:500) labeled with a secondary antibody (Alexa 405) (1:500), stained using a Zenon labeling kit (Invitrogen); an anti-mu-1A polyclonal antibody (1:10,000); and an anti-HLA-ABC MAb (W6/32) (1:5,000). The samples were examined with a Digital Eclipse C1 confocal microscope (Nikon, Kanagawa, Japan).
Visualization of Nef N terminus based on the NMR model. Molecular structures were analyzed based on the nuclear magnetic resonance (NMR) model of the myristoylated Nef N terminus (Protein Data Bank [PDB] code 1QA5) (15) . Structures were visualized using PyMol (W. L. DeLano; http://pymol.org), and hydrophobic accessible surface areas were calculated with Surface Racer (45) .
Molecular modeling of the mu-1A subunit, the N-terminal region of Nef, and the complex of mu-1A with the N-terminal region of Nef. We constructed structural models of a human mu-1A protein with homology modeling, using two crystal structures of a rat AP-2 mu-2 subunit (PDB codes 1BW8 and 1HES) (32, 33) as the modeling templates, with the BioInfoBank Meta Server (http://meta.bioinfo.pl/). Homology modeling of mu-1A and structural models of the wild type (WT) and four mutants of the HIV-1 Nef N terminus (residues 9 to 26, with PDB code 1QA5 used as a modeling template) (15) was done using the SwissModel server (http: //swissmodel.expasy.org/workspace/). The mu-1A model was subjected to docking with Nef N-terminal models by the use of a ASEDock module (Ryoka Systems Inc., Tokyo, Japan) (16) operated in the Molecular Operating Environment (MOE). The precision of docking results determined with the ASEDock module is generally equivalent to the experimental error value (i.e., a few angstroms); a result of dTTP docking with the ASEDock at the catalytic site in a reverse transcriptase (RT) closed configuration had a root-mean-square deviation of about 1.6 Å compared to that determined by X-ray crystallography (1RTD), which was a range within the resolution of the crystal structure (8) . Potential sites of binding of mu-1A to the Nef peptides were searched with SiteFinder module and selected on the basis of analogy to the interaction between mu-2 and the Yxx⌽ motif (32, 33) . Upon reviewing the results of the simulations, we considered the conformational flexibilities of peptide and side chains of mu-1A. Conformations of both main and side chains of the Nef peptides were randomly searched, and the Nef peptide models were automatically arranged in the binding cleft of mu-1A. Energy minimization of the peptide-mu-1A complex was performed under conditions in which the side chain atoms in mu-1A and all atoms in the peptide were not constrained but the main chain atoms in the mu-1A were tethered with 100 kcal/mol/Å 2 . The AMBER ff99 force field (47) and the generalized Born/ volume integral (GB/VI) implicit solvent model (22) were applied for the modeling. The three-dimensional (3D) structures were thermodynamically optimized by energy minimization using the MOE package and the same force field. A physically unacceptable local structure of the optimized 3D model was further assessed and refined on the basis of Ramachandran plot evaluation using the MOE package and 3D structure evaluation with Verify3D software (http://nihserver.mbi.ucla.edu/Verify _3D/) (26) .
MD simulation. To estimate the binding affinity of a Nef N-terminal region to the mu-1A subunit, we performed molecular dynamics (MD) simulations and the subsequent binding energy calculations with AMBER 9 software (35) . For the top-ranked model of the docking simulation of mu-1A and each Nef, a 1.5-ns (10 Ϫ9 s) MD simulation was initiated at 300°K (26.85°C) with a time step of 1.0 fs (10 Ϫ15 s). The AMBER ff99SB force field (19) and the GB implicit solvent model (IGB ϭ 5) (31) were applied for potential energy calculations. The cutoff for long-distanceinteraction energy was set at 15.0 Å, and the SHAKE algorithm was applied for bonds concerning hydrogen atoms. Subsequently, using 500 tra-jectories during 1.0 to 1.5 simulations, we estimated approximated values of binding energy (⌬Gb) between mu-1A and each Nef by the molecular mechanics/Poisson-Boltzmann surface area (MM/PBSA) method (21) . The AMBER ff99SB force field and the PBSA methods (25) were applied for potential energy calculations. The PBSA method is more timeconsuming but more accurate than the GB method. The cutoff value was applied for calculations of long-distance-interaction energy.
Coimmunoprecipitation. For immunoprecipitation, we used an antigamma-adaptin MAb, which was reported previously to coimmunoprecipitate the mu-1A subunit (11), or an anti-NeuN MAb, which expresses only in neural cells, as a negative control. At 20 h after HIV-1 infection, Jurkat cells were incubated with 20 mM NH 4 Cl for 4 h. It was confirmed that this treatment did not influence the levels of MHC-I downregulation in the infected Jurkat cells. We harvested and lysed the cells with lysis buffer (1% digitonin, 150 mM NaCl, 50 mM Tris-HCl [pH 7.0], 1 mM CaCl 2 , 1 mM MgCl 2 , Complete Mini) for 20 min on ice. The lysates were centrifuged at 6,000 rpm for 1 min at 4°C, and the supernatants were recovered and precleared with 50 l of Dynabeads (Invitrogen) for 1 h at 4°C. Also, 50 l of beads and antibodies were mixed and incubated for 90 min at 4°C to form the bead-Ig complexes. The complexes were washed once with the lysis buffer, the precleared supernatant was added, and the mixture was incubated for 90 min at 4°C for immunoreactions. After the immunoreactions, the beads were washed 4 times with lysis buffer. The immunoprecipitated materials were eluted with 40 l of 0.1% citrate at room temperature, 2ϫ sample buffer was added, and the mixture was boiled for 5 min at 95°C. The samples were analyzed by Western blotting. Input controls were 1/50 of the volume of the immunoprecipitated protein. Consistent results were obtained from three independent experiments.
RESULTS

Analysis of the importance of the N-terminal region of Nef for MHC-I downregulation.
A basic cluster (Arg17, -19, -21, and -22) is relatively conserved among Nef proteins of various HIV-1 subtypes. It has been shown that the basic cluster supports plasma membrane binding of myristoylated proteins by contributing electrostatic interactions with negatively charged acidic phospholipids such as phosphatidylserine and phosphatidylinositol at the cytosolic surface of the plasma membrane (38) . We therefore hypothesized that Met20 and the basic cluster could cooperatively contribute to the MHC-I downregulation. To evaluate this possibility, we analyzed the function of a Nef variant referred to as the R mutant in which the Arg residues were replaced by Ala (Fig. 1A) . First, we determined the expression of Nef mutants and confirmed that WT Nef and its variants were intracellularly expressed at comparable levels. Virion packaging was less efficient in the R mutant (Fig. 1B) , as previously shown (48) . Next, we analyzed the effect of the mutations on the MHC-I downregulation. WT Nef clearly downregulated MHC-I on the surface of the HIV-1-infected T cells, while the Nef(Ϫ), M20A, M20R, and ⌬62-68 variants lost the ability to downregulate MHC-I (Fig. 1C, D , and E). Contrary to our expectations, the R mutant retained an ability to downregulate MHC-I nearly equivalent to that of the WT (Fig. 1C,  D , and E). In addition, the ability of the R mutant as well as the M20A, M20R, and ⌬62-68 variants to downregulate CD4 was comparable to that seen with WT Nef (Fig. 1E) . These results indicate that the reduced ability of the R mutant to incorporate into virions, which may be due to inefficient association with acidic phospholipids of the plasma membrane via electrostatic interactions as described previously (6), had no detectable effect on the MHC-I-regulatory function of Nef.
The N-terminal region of Nef has a number of conserved amino acid residues other than the basic cluster. It is conceivable that, in addition to Met20, they could cooperatively contribute to the Nef activity. In order to examine this possibility, we selected four residues as candidates, i.e., Gly12, Trp13, Val16, and Glu18, which are adjacent to Met20 and are relatively conserved among various HIV-1 subtypes. These residues were replaced with residues of a different electric charge or length of side chain ( Fig. 2A) . It was confirmed that the characteristics of expression as well as virion incorporation of these mutants were comparable (Fig. 2B) . Interestingly, replacement of Trp13 by Ala but not by Tyr and of Val16 by Glu or Arg but not by Ala affected the Nef effect (Fig. 2C,  D , and E). All these mutants were comparable to WT Nef in their ability to downregulate CD4 (Fig. 2E) . Moreover, it was confirmed that double (W13A/V16R) and triple (W13A/V16R/ M20A) substitution mutants of Nef also lost the ability to downregulate MHC-I but remained active with respect to CD4 (data not shown). Taken together, our data indicated that, in addition to Met20, the Trp13 and Val16 residues in Nef were critical for the MHC-I downregulation.
The significance of the tripartite residues for MHC-I downregulation. In order to get insights into the structural properties of the tripartite Trp13, Val16, and Met20 (WVM) motif in Nef, we projected our results onto the NMR structure of the myristoylated Nef N terminus (PDB entry 1QA5) (15) . Residues Val16 and Met20 were located on the same side of the N-terminal ␣-helix of Nef. In contrast, Arg17, -19, -21, and -22 residues were located on the opposite side of the ␣-helix, thus creating a basic surface. Trp13 was positioned immediately upstream of the N-terminal helix, with its hydrophobic side chain pointing in the same direction as those of Val16 and Met20 (Fig. 3A) . Together, Trp13, Val16, and Met20 formed a hydrophobic surface of about 375 Å 2 . These results may explain why the basic cluster adjacent to the Met20 comprised of Arg17, -19, -21, and -22 is dispensable for MHC-1 downregulation. The mu-1A subunit of AP-1 has been shown to recognize binding motifs in the cytoplasmic tail of cargo proteins and binds them with the binding pockets. One of sorting motifs is an acidic dileucine motif (ED]xxxL[L), and the other is a tyrosine motif (Yxx⌽; ⌽ represents bulky hydrophobic amino acids, which can be phenylalanine, isoleucine, leucine, methionine, or valine) (6a). Considering our finding that the replacement of Trp13 by Tyr but not Ala maintained the Nef effect on MHC-1 downregulation (Fig. 2) , we hypothesized that Trp13 and Val16 could act as a noncanonical mu-1A-binding motif. To test this, we undertook docking simulations in terms of the interaction between the tyrosine motif-binding site of the mu-1A subunit and the N-terminal region of Nef. Based on the NMR structures of these proteins, we simulated the docking of the N-terminal region of Nef with mu-1A (Fig. 3B ). An aromatic ring of the Trp13 of WT Nef was specifically placed in the front face of two aromatic rings of Phe18 and/or Trp 240 in mu-1A, contributing to hydrophobic interactions with the Nef N-terminal region. Protruding side chains of Met20 and Val16 of WT Nef were specifically embedded in a bowl shape of the hydrophobic cavity in the binding surface of mu-1A. In contrast, side chains of Arg17, -19, -21, and -22 residues were positioned in the direction opposite the mu-1A-binding surface. In addition, these hydrophobic interactions were well preserved in W13Y and R but not in W13A and M20A. Consequently, the binding configurations of these molecules were similar in the WT, W13Y, and R but not in W13A and M20A (Fig. 3B) .
We then evaluated the influence of mutations on the binding free energy, ⌬G b , which indicates the binding strength between Nef and mu1A (Fig. 3B) . The ⌬G b s of W13Y and the R mutant were nearly equal to that of the WT, whereas those of W13A and M20A were much lower, consistent with interaction modes of these variants in the structural models. These structural data were consistent with the results from the functional analyses presented in Fig. 2 and support our hypothesis that Trp13 and Val16 can form a noncanonical mu-1A-binding motif. Of note, the results from the interaction model showed that the hydrophobic motif of the WT Nef fitted only poorly onto mu-2, the subunit of AP-2, because of a poor fit of Met20 onto the mu-2-binding surface. Consequently, the ⌬G b between the N-terminal region of Nef and mu-2 was much lower than that of Nef and mu-1A (Fig. 3C) . These results may explain why Met20 is critical for the selective binding of Nef to mu-1A, and the result is consistent with our finding that the N terminus of Nef is important for the downregulation of MHC-I but not of CD4.
The results of the computer simulation strongly suggest that the tripartite WVM motif contributes to the interaction of Nef with mu-1A. We further analyzed the intracellular localization in order to ascertain results from the docking simulation analyses. Immunofluorescence staining demonstrated that WT Nef but not M20A or W13A significantly colocalized with MHC-I and mu-1A and reduced the surface expression of MHC-I (Fig. 4A) . Moreover, we sought to confirm the interaction of Nef with mu-1A by coimmunoprecipitation (Fig. 4B) . Comparable levels of gamma and mu-1A subunits of the adapter complex as well as Nef were detected among the samples harvested from the Jurkat cells expressing WT Nef and its variants. Importantly, an anti-gamma adaptin antibody coprecipitated mu-1A irrespective of the expression of Nef due to the formation of a hemicomplex as subunits of AP-1, and the antibody also coprecipitated WT Nef but not the M20A and W13A mutants.
DISCUSSION
In the present study, we addressed the question of how the amino acids in the N terminus of Nef functioned for MHC-I downregu- lation. We show here for the first time that Nef specifically interacts with the mu-1A subunit of AP-1 through the WVM domain and that Trp13 and Val16, in addition to Met20, are involved as a novel motif, which was evident from the present data obtained from functional, biochemical, structural, and in silico analyses.
We show here that the hydrophobic motif composed of Trp13, Val16, and Met20 interacts with mu-1A at the tyrosine motifbinding site. It is notable that Trp13 is highly conserved among HIV-1 subtypes whereas Val16 and Met20 are not necessarily conserved and V16I and M20I substitutions are also observed. In accordance with this point of view, we constructed structural models of mu-1A docked to the Nef N-terminal peptides containing a W13F, W13K, W13I, V16I, or M20I substitution. The models suggest that these peptides exert binding configurations comparable to that of wild-type Nef peptide, except for M20I, which appears to exhibit a substantial influence compared with the others (data not shown). Importantly, HIV-1 subtype C and simian immunodeficiency virus cpz (SIVcpz) Nef clones with the M20I substitution have been demonstrated to be functional in terms of the ability to downregulate MHC-I (18, 43, 46) . Taken together, our results indicate that the hydrophobic patch interacts with mu-1A at the YXX⌽-binding site in a noncanonical manner and that the substitutions may not affect the MHC-I-regulatory function, which in turn implies that the highly conserved Trp13 could play a critical role for another function in Nef. These issues remain to be further elucidated.
The unique positioning of Met20 in the tripartite hydrophobic motif compared with the canonical tyrosine motif indicates that it is a critical residue to compensate for the absence of Tyr at position 13 and to selectively interact with mu-1A. Consistent with this notion, mu-2 showed much lower free binding energy than mu-1A due to the absence of an appropriate pocket structure such as is required for the interaction with the side chain of Met20 (Fig.  3C) . It has been reported that Nef downregulates both MHC-I and CD4 through interaction with AP-1 and AP-2, respectively, and that a dileucine motif and a diacidic motif in the C terminus of Nef interact with the mu-2 subunit of AP-2 (12), while the molecular basis for the selective interaction of Nef with AP-1 and AP-2 remains to be elucidated. The present data showing that the hydrophobic motif in the N terminus of Nef specifically interacts with mu-1A of AP-1 explain the molecular mechanism for the differential effects of Nef on MHC-I and CD4.
Collins's group demonstrated that M20 was critical for the association of Nef with mu-1 as well as MHC-I downregulation (40, 49) , which is consistent with our present results. In contrast, Singh et al. indicated in their report that M20 had little or no effect on the binding of Nef with mu-1 (42) . This discrepancy may be due to differences in the assay systems used for detection of binding of Nef and mu-1, i.e., we as well as Collins's group employed T lymphocytes expressing Nef in a coimmunoprecipitation study as well as an MHC-I downregulation assay, whereas Singh et al. used an MHC-I-CD-Nef chimera and mu-1 expressed in Escherichia coli in an in vitro binding assay. We believe that the former approach should better represent the physiological machinery by which Nef exerts intrinsic activity.
In this study, we have found that the N-terminal region around the Met20 residue in Nef includes two separable functional motifs: an Arg-rich basic cluster and a noncanonical mu-1A-binding motif. Albeit overlapping in the primary structure, the two motifs were separable on the 3D structure of this region, as shown in Fig.   3 . Previous reports have shown that the basic cluster supports plasma membrane binding of the myristoylated protein, including Src, MARCKS, and HIV-1 Gag, by contributing electrostatic interactions with negatively charged acidic phospholipids such as phosphatidylserine and phosphatidylinositol at the cytosolic surface of the plasma membrane (38) and also that the N-myristoylation is essential for the Nef-mediated biological activities, including MHC-I downregulation (2) . We therefore hypothesized that Met20, together with the basic cluster, could play a critical role for the MHC-I downregulation. However, contrary to our assumption, the basic cluster was dispensable for the ability of Nef to downregulate MHC-I (Fig. 1) , suggesting that that ability is independent of the association of Nef with phospholipids. Since Nef protein tends to localize to both the plasma membrane and perinuclear compartment (13) , it is still possible that the myristoyl moiety could contribute to the MHC-I downregulation by way of association with the TGN or endosomes. This is in agreement with a previous report showing that the assembly of a complex that includes Nef, MHC-I, and AP-1 early in the secretory pathway is important for the MHC-I downregulation (20) .
